[go: up one dir, main page]

NO991047D0 - Transdermal therapeutic approach involving a combination of active substances containing ° striol - Google Patents

Transdermal therapeutic approach involving a combination of active substances containing ° striol

Info

Publication number
NO991047D0
NO991047D0 NO991047A NO991047A NO991047D0 NO 991047 D0 NO991047 D0 NO 991047D0 NO 991047 A NO991047 A NO 991047A NO 991047 A NO991047 A NO 991047A NO 991047 D0 NO991047 D0 NO 991047D0
Authority
NO
Norway
Prior art keywords
active substances
striol
combination
transdermal therapeutic
therapeutic approach
Prior art date
Application number
NO991047A
Other languages
Norwegian (no)
Other versions
NO991047L (en
Inventor
Reinhard Von Kleinsorgen
Britta Von Kleinsorgen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO991047D0 publication Critical patent/NO991047D0/en
Publication of NO991047L publication Critical patent/NO991047L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Disclosed is a transdermal therapeutical approach involving oestriol as an active substance, characterized in that oestriol is combined with one or more active substances.
NO991047A 1996-09-04 1999-03-03 Transdermal therapeutic approach involving a combination of active substances containing ° striol NO991047L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19635883A DE19635883A1 (en) 1996-09-04 1996-09-04 Transdermal therapeutic system with an active ingredient combination containing estriol
PCT/EP1997/004392 WO1998009631A1 (en) 1996-09-04 1997-08-13 Transdermal therapeutical approach involving a combination of active substances containing oestriol

Publications (2)

Publication Number Publication Date
NO991047D0 true NO991047D0 (en) 1999-03-03
NO991047L NO991047L (en) 1999-03-03

Family

ID=7804611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991047A NO991047L (en) 1996-09-04 1999-03-03 Transdermal therapeutic approach involving a combination of active substances containing ° striol

Country Status (17)

Country Link
EP (1) EP0927036B9 (en)
JP (1) JP2000517324A (en)
KR (1) KR20010029451A (en)
CN (1) CN1228702A (en)
AT (1) ATE289818T1 (en)
AU (1) AU729898B2 (en)
CA (1) CA2261655A1 (en)
CZ (1) CZ70099A3 (en)
DE (2) DE19635883A1 (en)
ES (1) ES2239362T3 (en)
IL (1) IL128768A0 (en)
NO (1) NO991047L (en)
NZ (1) NZ334443A (en)
PL (1) PL332035A1 (en)
SK (1) SK25299A3 (en)
WO (1) WO1998009631A1 (en)
ZA (1) ZA977895B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101873859A (en) 2007-12-10 2010-10-27 考司美德制药株式会社 transdermal patch

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
CA2101275C (en) * 1991-02-26 1998-08-04 Jocelyn Elaine Mcosker Methods for the treatment of osteoporosis
JPH07504672A (en) * 1992-03-21 1995-05-25 エンテック　ゲゼルシャフト　フュア　エンドクリノロギッシェ　テヒノロギー　エム．ベー．ハー． Use of estriol for the treatment of menopausal osteoporosis
JPH0679002A (en) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc Patch device for percutaneous administration
DE4405898A1 (en) * 1994-02-18 1995-08-24 Schering Ag Transdermal therapeutic systems containing sex steroids

Also Published As

Publication number Publication date
DE59712215D1 (en) 2005-04-07
KR20010029451A (en) 2001-04-06
AU4015097A (en) 1998-03-26
CA2261655A1 (en) 1998-03-12
EP0927036A1 (en) 1999-07-07
ATE289818T1 (en) 2005-03-15
SK25299A3 (en) 2000-08-14
EP0927036B9 (en) 2005-08-10
CZ70099A3 (en) 1999-07-14
PL332035A1 (en) 1999-08-16
ES2239362T3 (en) 2005-09-16
EP0927036B1 (en) 2005-03-02
JP2000517324A (en) 2000-12-26
AU729898B2 (en) 2001-02-15
CN1228702A (en) 1999-09-15
NZ334443A (en) 1999-08-30
WO1998009631A1 (en) 1998-03-12
DE19635883A1 (en) 1998-03-05
ZA977895B (en) 1998-03-02
NO991047L (en) 1999-03-03
IL128768A0 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
EA199900553A1 (en) Percutaneous therapy system
ID21863A (en) COMPOUNDS OF KINOLIN AND KINAZOLIN USED IN THERAPY, SPECIFICALLY IN TREATMENT OF TYPICAL PROSTATIC HEPERPLASIA
TR199801180T2 (en) New compounds with analgesic effect.
SE8504720L (en) NEW PHARMACEUTICAL PREPARATION
NO951592L (en) Process for the preparation of a transdermal therapeutic system
DK0596903T3 (en) Transdermal, therapeutic systems.
SE8803486L (en) DOSAGE FOR TREATMENT OF CARDIOVASCULAR DISEASES
AU8970198A (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in thetreatment of pain
DE69824164D1 (en) MEDICINAL PREPARATIONS FOR TREATING SEXUAL FUNCTIONAL DISORDERS
NO992408D0 (en) Process for Low Waste Preparation of Sliced Formulas Containing Active Ingredients, and Transdermal Therapeutic Systems Containing the Same
DE69633396D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ACTIVIN STIMULATOR
NO864131D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOL AND INDAZOL-KETOSULPHONE DERIVATIVES.
MX9701968A (en) Scopolamine plaster.
TR199802351T2 (en) Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use.
DK1032378T3 (en) Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
WO1997030714A3 (en) Topical pharmaceutical composition containing heparin
TR199801184T2 (en) New compounds with analgesic action.
NO991047L (en) Transdermal therapeutic approach involving a combination of active substances containing ° striol
DK131586A (en) TRANSDERMAL, ANTIALLERGIC, PHARMACEUTICAL PREPARATION
FI901876A7 (en) Incomplete hepadnaviruses, vaccine-producing cell lines, and treatment of liver diseases
NO20000376D0 (en) Transdermal therapeutic system for releasing active substance through the skin into an organism and method of application to the skin
ATE280575T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE USE OF CANDESARTAN
NO892871D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RELATIONS.
NO981020D0 (en) Transdermal therapeutic system for silatran compounds
FI870557A7 (en) Dermal and transdermal patches.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application